life sciences IP

IP News

EPO Reveals 12 Finalists for European Inventor Award 2026: Malaria Vaccine, Quantum Sensing, and Semiconductor Probe Cards Among Honorees

On May 13, 2026, the EPO unveiled 12 finalists for the European Inventor Award 2026. Honorees include Sir Adrian Hill (R21/Matrix-M malaria vaccine), Mikko Möttönen (cryogenic quantum sensing), and Technoprobe (semiconductor probe cards) across Industry, Research, SMEs and Non-EPO Countries. Ceremony in Berlin on July 2.
IP News

Federal Circuit Reinstates $177 Million Verdict in Teva v. Lilly CGRP Antibody Patent Case

The U.S. Court of Appeals for the Federal Circuit reinstated a $177 million jury verdict in Teva Pharmaceuticals Interna...
IP News

U.S. Supreme Court to Hear Oral Arguments April 29 in Hikma v. Amarin — Skinny Label and Induced Infringement Standard at Stake

The U.S. Supreme Court is scheduled to hear oral arguments on April 29, 2026, in Hikma Pharmaceuticals USA Inc. v. Amari...
IP News

Japan IP High Court Revives Broad Institute’s CRISPR Patent, Overturning JPO Priority Rights Ruling

Japan's Intellectual Property High Court (IP High Court) has overturned a Japan Patent Office (JPO) decision invalidatin...
IP News

Federal Circuit Revives $177 Million Jury Verdict in Teva v. Eli Lilly CGRP Patent Dispute, Distinguishing Amgen

The U.S. Court of Appeals for the Federal Circuit on April 16, 2026 reversed a district court's grant of judgment as a m...
IP News

Trump Administration Imposes Up to 100 Percent Tariffs on Patented Pharmaceuticals: The IP Implications of Excluding Generics

Up to 100% tariffs on patented drugs, generics exempt. How patent status became the dividing line for U.S. trade policy.
IP News

USPTO’s First Life Sciences PTAB Listening Session Surfaces Fundamental Divide Over Patent Validity and Drug Competition

The U.S. Patent and Trademark Office convened the first of three planned listening sessions on March 30, 2026, to examin...
IP News

CRISPR Patent War: UC Berkeley vs. Broad Institute and the Battle Over Gene Editing’s Crown

The decade-long CRISPR-Cas9 patent war between UC Berkeley's Jennifer Doudna and Broad Institute's Feng Zhang reshaped biotech IP forever. A deep investigation into the interference proceedings, Nobel Prize, and what it means for medicine.